These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

171 related items for PubMed ID: 9816271

  • 1. Molecular staging of non-small cell lung cancer according to K-ras genotypes.
    Rosell R, Monzó M, Pifarré A, Ariza A, Sánchez JJ, Moreno I, Maurel J, López MP, Abad A, de Anta JM.
    Clin Cancer Res; 1996 Jun; 2(6):1083-6. PubMed ID: 9816271
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. A novel molecular staging protocol for non-small cell lung cancer.
    Miyake M, Adachi M, Huang C, Higashiyama M, Kodama K, Taki T.
    Oncogene; 1999 Apr 08; 18(14):2397-404. PubMed ID: 10327061
    [Abstract] [Full Text] [Related]

  • 4. Prognostic impact of mutated K-ras gene in surgically resected non-small cell lung cancer patients.
    Rosell R, Li S, Skacel Z, Mate JL, Maestre J, Canela M, Tolosa E, Armengol P, Barnadas A, Ariza A.
    Oncogene; 1993 Sep 08; 8(9):2407-12. PubMed ID: 8395679
    [Abstract] [Full Text] [Related]

  • 5. P53 and K-ras mutations are frequent events in microscopically negative surgical margins from patients with nonsmall cell lung carcinoma.
    Jassem J, Jassem E, Jakóbkiewicz-Banecka J, Rzyman W, Badzio A, Dziadziuszko R, Kobierska-Gulida G, Szymanowska A, Skrzypski M, Zylicz M.
    Cancer; 2004 May 01; 100(9):1951-60. PubMed ID: 15112277
    [Abstract] [Full Text] [Related]

  • 6. Detection of K-ras and p53 mutations in bronchoscopically obtained malignant and non-malignant tissue from patients with non-small cell lung cancer.
    Lang SM, Stratakis DF, Freudling A, Ebelt K, Oduncu F, Hautmann H, Huber RM.
    Eur J Med Res; 2000 Aug 18; 5(8):341-6. PubMed ID: 10958767
    [Abstract] [Full Text] [Related]

  • 7. ras gene mutations in non-small cell lung cancers are associated with shortened survival irrespective of treatment intent.
    Mitsudomi T, Steinberg SM, Oie HK, Mulshine JL, Phelps R, Viallet J, Pass H, Minna JD, Gazdar AF.
    Cancer Res; 1991 Sep 15; 51(18):4999-5002. PubMed ID: 1654209
    [Abstract] [Full Text] [Related]

  • 8. Mutations of K-ras oncogene and absence of H-ras mutations in squamous cell carcinomas of the lung.
    Vachtenheim J, Horáková I, Novotná H, Opáalka P, Roubková H.
    Clin Cancer Res; 1995 Mar 15; 1(3):359-65. PubMed ID: 9815992
    [Abstract] [Full Text] [Related]

  • 9. p53 gene mutations in non-small-cell lung cancer cell lines and their correlation with the presence of ras mutations and clinical features.
    Mitsudomi T, Steinberg SM, Nau MM, Carbone D, D'Amico D, Bodner S, Oie HK, Linnoila RI, Mulshine JL, Minna JD.
    Oncogene; 1992 Jan 15; 7(1):171-80. PubMed ID: 1311061
    [Abstract] [Full Text] [Related]

  • 10. Association of the DNA repair gene XPD Asp312Asn polymorphism with p53 gene mutations in tobacco-related non-small cell lung cancer.
    Gao WM, Romkes M, Day RD, Siegfried JM, Luketich JD, Mady HH, Melhem MF, Keohavong P.
    Carcinogenesis; 2003 Oct 15; 24(10):1671-6. PubMed ID: 12844488
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Mutations of ras genes distinguish a subset of non-small-cell lung cancer cell lines from small-cell lung cancer cell lines.
    Mitsudomi T, Viallet J, Mulshine JL, Linnoila RI, Minna JD, Gazdar AF.
    Oncogene; 1991 Aug 15; 6(8):1353-62. PubMed ID: 1679529
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. GSTM1, P53 and K-ras molecular detection in resectable non-small cell lung cancer by denaturing gradient gel electrophoresis-bronchoalveolar lavage fluid analysis.
    Curigliano G, Ferretti G, Mandalà M, De Pas T, Calabrò MG, Solli P, Noberasc C, de Braud F.
    Anticancer Res; 2001 Aug 15; 21(5):3461-9. PubMed ID: 11848510
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. APC, K-ras, and p53 gene mutations in colorectal cancer patients: correlation to clinicopathologic features and postoperative surveillance.
    Hsieh JS, Lin SR, Chang MY, Chen FM, Lu CY, Huang TJ, Huang YS, Huang CJ, Wang JY.
    Am Surg; 2005 Apr 15; 71(4):336-43. PubMed ID: 15943410
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. K-ras mutations are a relatively late event in the pathogenesis of lung carcinomas.
    Sugio K, Kishimoto Y, Virmani AK, Hung JY, Gazdar AF.
    Cancer Res; 1994 Nov 15; 54(22):5811-5. PubMed ID: 7954406
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.